SpinalCyte Issued Canadian Patent for Spinal Disc Tissue Engineering Technology

SpinalCyte was issued Canadian Patent No. 2,641,170, “Methods and Compositions for Repair of Cartilage using an In Vivo Bioreactor."

The technology, which supports tissue engineering, incorporates a synthetic polymer matrix, a natural hydrogel or a synthetic hydrogel to expose fibroblasts to a mechanical strain using intermittent...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us